Cohen & Steers, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to institutional investors, including pension funds, endowments, and foundations. It manages separate client-focused equity, fixed income, multi-asset, and commodity portfolios through its subsidiaries. The firm launches and manages equity, fixed income, balanced, and multi-asset mutual funds through its subsidiaries. Through its subsidiaries, it also launches and manages hedge funds. The firm invests in public equity, fixed income, and commodity markets across the globe through its subsidiaries. Through its subsidiaries, it invests in companies operating in the real estate sector, including real estate investment trusts, infrastructure sector, and natural energy resources sector for its equity and fixed income investments. The firm also invests in preferred securities for its fixed income investments through its subsidiaries. The firm is a leading global investment manager specializing in real assets and alternative income, including real estate, preferred securities, infrastructure, resource equities, commodities, as well as multi-strategy solutions. Cohen & Steers, Inc. was founded in 1986 and is based in New York.

Cohen & Steers Inc

The latest update is out from Constellation Software ( ($TSE:CSU) ). Constellation Software Inc. has announced the appointment of Mark Miller to it...

Constellation Software Appoints Mark Miller to Board of Directors

Constellation Software ( ($TSE:CSU) ) has shared an update. Constellation Software’s Lumine Group has announced a definitive agreement to acquire S...

Lumine Group to Acquire Synchronoss Technologies in Strategic Expansion

An update from Dai-ichi Life Holdings ( ($JP:8750) ) is now available. Dai-ichi Life Holdings announced corrections to its previous notice regardin...

Dai-ichi Life Holdings Adjusts Share Repurchase Timeline

In a report released on December 1, Paul Treiber from RBC Capital maintained a Buy rating on Constellation Software, with a price target of C$5,600...

New Buy Rating for Constellation Software (CSU), the Technology Giant

CNS Pharmaceuticals ( ($CNSP) ) just unveiled an update. On November 17, 2025, CNS Pharmaceuticals held its Annual Meeting where stockholders appro...

CNS Pharmaceuticals Increases Authorized Shares for Growth

XRP (XRP-USD) stumbled into the new week under renewed pressure, sliding to about $2.14 and exposing deeper cracks in its market structure. New dat...

XRP Sinks Below $2.15 as Analysts Warn Market Has Become ‘Structurally Fragile.’ Here’s Why.

Constellation Software ( ($TSE:CSU) ) just unveiled an update. Constellation Software’s Harris Operating Group has successfully completed the acqui...

Current Quarter	$0.81	Next Quarter	$NA
Current Year	$3.09	Next Year	$3.38
QoQ Growth	NaN%	YoY Growth	+9.4%
3Y EPS CAGR	-11.8%	Target Price	$70.00
Consensus	Buy	Upside	+10.9%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CNS	$63.10	+0.90%	106.64K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CNS	$63.10	+0.9%	106.64K
3
4
5
6

CNS

CNS

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Cohen & Steers Inc Data in Excel

Get Cohen & Steers Inc Data in Excel